Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

The relationship between skin checking and sun protection behaviours: implications for skin cancer prevention campaigns.

Jongenelis M, Pettigrew S, Strickland M, Minto C, Slevin T.

Public Health. 2018 Feb;155:55-58. doi: 10.1016/j.puhe.2017.11.009. Epub 2018 Jan 4. No abstract available.

PMID:
29306623
2.

Wearable Devices for Caloric Intake Assessment: State of Art and Future Developments.

Magrini ML, Minto C, Lazzarini F, Martinato M, Gregori D.

Open Nurs J. 2017 Oct 31;11:232-240. doi: 10.2174/1874434601711010232. eCollection 2017. Review.

3.

Electronic Questionnaires Design and Implementation.

Minto C, Vriz GB, Martinato M, Gregori D.

Open Nurs J. 2017 Oct 31;11:157-202. doi: 10.2174/1874434601711010157. eCollection 2017. Review.

4.

Anchoring Vignettes in EQ-5D-5L Questionnaire: Validation of a New Instrument.

Azzolina D, Minto C, Boschetto S, Martinato M, Bauce B, Iliceto S, Gregori D.

Open Nurs J. 2017 Oct 31;11:144-156. doi: 10.2174/1874434601711010144. eCollection 2017.

5.

Characteristics of the Mortality Information System in municipalities of São Paulo State, Brazil, 2015.

Minto CM, Alencar GP, Almeida MF, Silva ZPD.

Epidemiol Serv Saude. 2017 Oct-Dec;26(4):869-880. doi: 10.5123/S1679-49742017000400017. Portuguese, English.

6.

Definition of a tolerable upper intake level of niacin: a systematic review and meta-analysis of the dose-dependent effects of nicotinamide and nicotinic acid supplementation.

Minto C, Vecchio MG, Lamprecht M, Gregori D.

Nutr Rev. 2017 Jun 1;75(6):471-490. doi: 10.1093/nutrit/nux011. Review.

PMID:
28541582
7.

Disposition of Remifentanil in Obesity: A New Pharmacokinetic Model Incorporating the Influence of Body Mass.

Kim TK, Obara S, Egan TD, Minto CF, La Colla L, Drover DR, Vuyk J, Mertens M; the Remifentanil Pharmacokinetics in Obesity Investigators.

Anesthesiology. 2017 Jun;126(6):1019-1032. doi: 10.1097/ALN.0000000000001635.

PMID:
28509796
8.

Trends in Australian adolescents' sun-protection behaviours: implications for health campaigns.

Koch S, Pettigrew S, Hollier LP, Slevin T, Strickland M, Minto C, Jalleh G, Lin C.

Aust N Z J Public Health. 2016 Oct;40(5):468-473. doi: 10.1111/1753-6405.12561. Epub 2016 Aug 14.

PMID:
27523880
9.

Predictors of sun protection behaviours and sunburn among Australian adolescents.

Pettigrew S, Jongenelis M, Strickland M, Minto C, Slevin T, Jalleh G, Lin C.

BMC Public Health. 2016 Jul 13;16:565. doi: 10.1186/s12889-016-3197-4.

10.

Assessing the potential to combine attitude tracking and health campaign evaluation surveys.

Hollier LP, Pettigrew S, Minto C, Slevin T, Strickland M.

Health Promot J Austr. 2016 Apr 6;27(2):170-173. doi: 10.1071/HE15100.

PMID:
27048751
11.

Comparing online and telephone survey results in the context of a skin cancer prevention campaign evaluation.

Hollier LP, Pettigrew S, Slevin T, Strickland M, Minto C.

J Public Health (Oxf). 2017 Mar 1;39(1):193-201. doi: 10.1093/pubmed/fdw018.

PMID:
26968482
12.

Sunscreen Increasingly Overshadows Alternative Sun-Protection Strategies.

Koch S, Pettigrew S, Strickland M, Slevin T, Minto C.

J Cancer Educ. 2017 Sep;32(3):528-531. doi: 10.1007/s13187-016-0986-5.

PMID:
26792784
13.

Trends in sun-protection behaviour in Australian adults 2007-2012.

Koch S, Pettigrew S, Minto C, Slevin T, Strickland M, Lin C, Jalleh G.

Australas J Dermatol. 2017 May;58(2):111-116. doi: 10.1111/ajd.12433. Epub 2016 Jan 17.

PMID:
26776445
14.

The Safety of Target-Controlled Infusions.

Schnider TW, Minto CF, Struys MM, Absalom AR.

Anesth Analg. 2016 Jan;122(1):79-85. doi: 10.1213/ANE.0000000000001005. Review.

PMID:
26516801
15.

Is Internet use associated with anxiety in patients with and at risk for cardiomyopathy?

Minto C, Bauce B, Calore C, Rigato I, Folino F, Soriani N, Hochdorn A, Iliceto S, Gregori D.

Am Heart J. 2015 Jul;170(1):87-95, 95.e1-4. doi: 10.1016/j.ahj.2015.02.024. Epub 2015 Apr 9.

PMID:
26093868
16.

Predator decline leads to decreased stability in a coastal fish community.

Britten GL, Dowd M, Minto C, Ferretti F, Boero F, Lotze HK.

Ecol Lett. 2014 Dec;17(12):1518-25. doi: 10.1111/ele.12354. Epub 2014 Sep 16.

PMID:
25224645
17.

Interrater reliability assessment using the Test of Gross Motor Development-2.

Barnett LM, Minto C, Lander N, Hardy LL.

J Sci Med Sport. 2014 Nov;17(6):667-70. doi: 10.1016/j.jsams.2013.09.013. Epub 2013 Oct 18.

PMID:
24211133
18.

Context sensitive decrement times of remimazolam.

Schnider T, Minto C.

Anesth Analg. 2013 Jul;117(1):285. doi: 10.1213/ANE.0b013e3182942954. No abstract available.

PMID:
23788743
19.

Interactions between small pelagic fish and young cod across the north Atlantic.

Minto C, Worm B.

Ecology. 2012 Oct;93(10):2139-54.

PMID:
23185876
20.

Rebuilding global fisheries.

Worm B, Hilborn R, Baum JK, Branch TA, Collie JS, Costello C, Fogarty MJ, Fulton EA, Hutchings JA, Jennings S, Jensen OP, Lotze HK, Mace PM, McClanahan TR, Minto C, Palumbi SR, Parma AM, Ricard D, Rosenberg AA, Watson R, Zeller D.

Science. 2009 Jul 31;325(5940):578-85. doi: 10.1126/science.1173146.

21.

Contributions of PK/PD modeling to intravenous anesthesia.

Minto CF, Schnider TW.

Clin Pharmacol Ther. 2008 Jul;84(1):27-38. doi: 10.1038/clpt.2008.100. Epub 2008 May 7. Review.

PMID:
18463625
22.

Survival variability and population density in fish populations.

Minto C, Myers RA, Blanchard W.

Nature. 2008 Mar 20;452(7185):344-7. doi: 10.1038/nature06605.

PMID:
18354480
23.

Pharmacokinetic models of propofol for TCI.

Schnider T, Minto C.

Anaesthesia. 2008 Feb;63(2):206; author reply 206-7. doi: 10.1111/j.1365-2044.2007.05419_1.x. No abstract available.

24.

Effect-site half-time for burst suppression is longer than for hypnosis during anaesthesia with sevoflurane.

Kennedy RR, Minto C, Seethepalli A.

Br J Anaesth. 2008 Jan;100(1):72-7. Epub 2007 Nov 12.

25.

XY females: revisiting the diagnosis.

Minto CL, Crouch NS, Conway GS, Creighton SM.

BJOG. 2005 Oct;112(10):1407-10.

26.

Female genital appearance: "normality" unfolds.

Lloyd J, Crouch NS, Minto CL, Liao LM, Creighton SM.

BJOG. 2005 May;112(5):643-6.

27.

Meeting between experts: evaluation of the first UK forum for lay and professional experts in intersex.

Creighton SM, Minto CL, Liao LM, Alderson J, Simmonds M.

Patient Educ Couns. 2004 Aug;54(2):153-7.

PMID:
15288908
28.

Age related changes of the PK-PD of intravenous anaesthetics.

Schnider TW, Minto CF.

Adv Exp Med Biol. 2003;523:45-56. Review. No abstract available.

PMID:
15088839
29.

Response surface modelling of drug interactions.

Minto C, Vuyk J.

Adv Exp Med Biol. 2003;523:35-43. Review. No abstract available.

PMID:
15088838
30.

[Modern concepts in pharmacokinetics of intravenous anesthetics].

Heidegger T, Minto CF, Schnider TW.

Anaesthesist. 2004 Jan;53(1):95-110. Review. German.

PMID:
14994741
31.

Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: a pilot study.

Crouch NS, Minto CL, Laio LM, Woodhouse CR, Creighton SM.

BJU Int. 2004 Jan;93(1):135-8.

PMID:
14678385
32.

Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.

Minto CF, Schnider TW, Gregg KM, Henthorn TK, Shafer SL.

Anesthesiology. 2003 Aug;99(2):324-33.

PMID:
12883405
33.

Sexual function in women with complete androgen insensitivity syndrome.

Minto CL, Liao KL, Conway GS, Creighton SM.

Fertil Steril. 2003 Jul;80(1):157-64.

PMID:
12849818
34.

Regarding the consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.

Creighton S, Ransley P, Duffy P, Wilcox D, Mushtaq I, Cuckow P, Woodhouse C, Minto C, Crouch N, Stanhope R, Hughes I, Dattani M, Hindmarsh P, Brain C, Achermann J, Conway G, Liao LM, Barnicoat A, Perry L.

J Clin Endocrinol Metab. 2003 Jul;88(7):3455; author reply 3456. No abstract available.

PMID:
12843205
35.

The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study.

Minto CL, Liao LM, Woodhouse CR, Ransley PG, Creighton SM.

Lancet. 2003 Apr 12;361(9365):1252-7.

PMID:
12699952
36.

The use of clinical supervision in secure environments.

Storey L, Minto C.

Br J Nurs. 2000 Nov 23-Dec 7;9(21):2226-31.

PMID:
12271174
37.

Vaginal adhesions caused by Stevens-Johnson syndrome.

Hart R, Minto C, Creighton S.

J Pediatr Adolesc Gynecol. 2002 Jun;15(3):151-2.

PMID:
12106751
38.

Concurrent ketamine and alfentanil administration: pharmacokinetic considerations.

Edwards SR, Minto CF, Mather LE.

Br J Anaesth. 2002 Jan;88(1):94-100.

PMID:
11881891
39.

Medical photography: ethics, consent and the intersex patient.

Creighton S, Alderson J, Brown S, Minto CL.

BJU Int. 2002 Jan;89(1):67-71; discussion 71-2. Review. No abstract available.

40.
41.

Predictors of onset and offset of drug effect.

Schnider TW, Minto CF.

Eur J Anaesthesiol Suppl. 2001;23:26-31.

PMID:
11766242
42.

Managing intersex.

Creighton S, Minto C.

BMJ. 2001 Dec 1;323(7324):1264-5. No abstract available.

43.

Magnetic resonance imaging in the assessment of complex Müllerian anomalies.

Minto CL, Hollings N, Hall-Craggs M, Creighton S.

BJOG. 2001 Aug;108(8):791-7.

44.
45.
46.

Response surface model for anesthetic drug interactions.

Minto CF, Schnider TW, Short TG, Gregg KM, Gentilini A, Shafer SL.

Anesthesiology. 2000 Jun;92(6):1603-16.

PMID:
10839909
47.

The influence of age on propofol pharmacodynamics.

Schnider TW, Minto CF, Shafer SL, Gambus PL, Andresen C, Goodale DB, Youngs EJ.

Anesthesiology. 1999 Jun;90(6):1502-16.

PMID:
10360845
48.

[Characterization of dose profile of remifentanil with computer simulation: comparative study with fentanyl and alfentanyl].

Gambús PL, Schnider TW, Minto CF.

Rev Esp Anestesiol Reanim. 1998 Oct;45(8):317-25. Spanish.

PMID:
9847642
49.

Expanding clinical applications of population pharmacodynamic modelling.

Minto C, Schnider T.

Br J Clin Pharmacol. 1998 Oct;46(4):321-33. Review.

50.

Pharmacokinetics of intravenous dynorphin A(1-13) in opioid-naive and opioid-treated human volunteers.

Gambús PL, Schnider TW, Minto CF, Youngs EJ, Billard V, Brose WG, Hochhaus G, Shafer SL.

Clin Pharmacol Ther. 1998 Jul;64(1):27-38.

PMID:
9695716

Supplemental Content

Support Center